Published in Nephrol Dial Transplant on January 01, 1994
Serum erythropoietin level and mortality in kidney transplant recipients. Clin J Am Soc Nephrol (2011) 0.79
Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways. PLoS One (2015) 0.76
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med (1998) 11.58
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science (1986) 2.84
The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem (1987) 2.78
Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem (1988) 2.46
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 2.11
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med (1997) 2.10
In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (1983) 1.97
Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol (1992) 1.92
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J Exp Med (1987) 1.85
Acute renal failure in critically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med (1991) 1.82
Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 1.80
A rapid biologic assay for the detection of interleukin 1. J Immunol (1983) 1.77
Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med (1987) 1.76
Human interleukin 1. Purification to homogeneity. J Exp Med (1985) 1.72
Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem (1986) 1.71
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A (1987) 1.65
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol (2000) 1.53
Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52
Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int (2000) 1.52
Lymphokine purification by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.51
A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol (2006) 1.49
Vascular access: concepts for the 1990s. J Am Soc Nephrol (1992) 1.44
Comparison of transposed brachiobasilic fistulas to upper arm grafts and brachiocephalic fistulas. Kidney Int (2001) 1.44
Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J Biol Chem (1994) 1.41
Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group. Kidney Int (2000) 1.35
Localization of human mononuclear cell interleukin 1. J Immunol (1987) 1.33
Renal infection in autosomal dominant polycystic kidney disease. Am J Med (1987) 1.20
Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. J Biol Chem (2000) 1.18
Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action. J Immunol (1982) 1.18
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis (1997) 1.17
Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients. Ann Thorac Surg (1997) 1.12
Anatomy of mitochondrial DNA from Paramecium aurelia. Mol Gen Genet (1980) 1.11
Survival in renal vascular disease. J Am Soc Nephrol (1998) 1.11
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand J Immunol (2006) 1.09
Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol (1997) 1.09
Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Intern Med (1989) 1.08
Correction of central venous stenoses: use of angioplasty and vascular Wallstents. Kidney Int (1994) 1.06
Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol (1999) 1.05
Treatment of infected tunneled venous access hemodialysis catheters with guidewire exchange. Kidney Int (1998) 1.03
Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line. J Immunol (1986) 1.02
Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J (1998) 1.01
A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect (2011) 1.00
Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99
Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int (1998) 0.99
MDRD-estimated GFR at one year post-renal transplant is a predictor of long-term graft function. Ren Fail (2008) 0.99
Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. J Immunol (1994) 0.98
A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant (2001) 0.98
IL 1 expression in a clone of human T cells. J Immunol (1987) 0.97
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int (2000) 0.97
Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells. J Immunol (1987) 0.97
Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of malfunction. Am J Kidney Dis (1996) 0.96
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int (2001) 0.96
IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha. J Immunol (1989) 0.94
Production of IL-1 alpha and IL-1 beta by clones of EBV transformed, human B cells. Mol Immunol (1987) 0.94
The impact of skin disease following renal transplantation on quality of life. Br J Dermatol (2005) 0.93
Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. Am J Kidney Dis (1986) 0.92
Limiting dilution analysis of interleukin 2 and colony-stimulating factor producer cells in normal and autoimmune mice. J Immunol (1984) 0.92
The treatment of induced immune deficiency with interleukin-2. Immunol Lett (1985) 0.91
Mechanisms of angioplasty in hemodialysis fistula stenoses evaluated by intravascular ultrasound. Kidney Int (1991) 0.91
Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation. Am J Kidney Dis (1999) 0.91
Prolonged expression of lipopolysaccharide (LPS)-induced inflammatory genes in whole blood requires continual exposure to LPS. Infect Immun (1995) 0.91
Predialysis systolic blood pressure correlates strongly with mean 24-hour systolic blood pressure and left ventricular mass in stable hemodialysis patients. J Am Soc Nephrol (1996) 0.91
Manifestations of Von Hippel Lindau syndrome: a retrospective national review. QJM (2013) 0.90
Generation of anti-peptide monoclonal antibodies which recognize mature CSF-2 alpha (IL 3) protein. J Immunol (1985) 0.89
Coronary artery bypass grafting in patients with dialysis-dependent renal failure. Ann Thorac Surg (1994) 0.89
Na+ gradient-dependent Pi uptake in basolateral membrane vesicles from dog kidney. Am J Physiol (1984) 0.88
Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology (2000) 0.88
A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol (1996) 0.88
In vivo treatment with IL-1 reduces the severity and duration of antigen-induced arthritis in rats. J Immunol (1988) 0.88
Partial characterization of three distinct populations of human gamma-crystallins. Invest Ophthalmol Vis Sci (1985) 0.88
Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail (1996) 0.87
Rabbit antithymocyte globulin related decrease in platelet count reduced risk of pediatric renal transplant graft thrombosis. Pediatr Transplant (2006) 0.87
Reactivity of monoclonal antibody E5 with endotoxin. I. Binding to lipid A and rough lipopolysaccharides. Circ Shock (1992) 0.87
Dialysis access infections. Curr Opin Nephrol Hypertens (2000) 0.87
Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection. Clin Transplant (2009) 0.87
SJL and NOD macrophages are uniquely characterized by genetically programmed, elevated expression of the IL-12(p40) gene, suggesting a conserved pathway for the induction of organ-specific autoimmunity. J Leukoc Biol (2001) 0.87
Pleuroperitoneal leak complicating peritoneal dialysis: a case series. Int J Nephrol (2011) 0.86
Minimizing hemorrhagic complications in dialysis patients. J Am Soc Nephrol (1991) 0.86
Granulocyte/macrophage colony stimulating factor. A potent activation signal for mature macrophages and monocytes. Int Arch Allergy Appl Immunol (1989) 0.86
Persistence of immune responses to altered and native myelin antigens in patients with multiple sclerosis treated with altered peptide ligand. Clin Immunol (2002) 0.86
Adequacy of haemodialysis with cuffed central-vein catheters. Nephrol Dial Transplant (1998) 0.86
Reactivity of monoclonal antibody E5 with endotoxin. II. Binding to short- and long-chain smooth lipopolysaccharides. Circ Shock (1992) 0.86
Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis. Kidney Int (1999) 0.85
Access recirculation in temporary hemodialysis catheters as measured by the saline dilution technique. Am J Kidney Dis (2000) 0.85
Clinical and pathologic features of familial focal segmental glomerulosclerosis. Am J Kidney Dis (1995) 0.85
Maintenance of permanent hemodialysis vascular access patency. ANNA J (1995) 0.84
Nature of hapten-modified determinants involved in induction of T cell tolerance and suppressor T cells to NDFB contact sensitivity. J Immunol (1980) 0.84
Malpositioned peritoneal dialysis catheters: a critical reappraisal of correction by stiff-wire manipulation. Am J Kidney Dis (1990) 0.84
Norepinephrine increases Na+-K+-ATPase and solute transport in rabbit proximal tubules. Am J Physiol (1987) 0.83